NATR vs NUS

For growth investors, Nature's Sunshine Products, Inc.

(NATR) is the stronger pick with 5. 7% revenue growth year-over-year, versus -14. 3% for Nu Skin Enterprises, Inc. (NUS). Nu Skin Enterprises, Inc. (NUS) offers the better valuation at 2. 3x trailing P/E (7. 3x forward), making it the more compelling value choice. Analysts rate Nature's Sunshine Products, Inc. (NATR) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Nu Skin Enterprises, Inc.

(NUS) is the cheapest at 2. 3x versus Nature's Sunshine Products, Inc. at 24. 8x. On forward P/E, Nu Skin Enterprises, Inc. is actually cheaper at 7. 3x.

Over the past 5 years, Nature's Sunshine Products, Inc.

(NATR) delivered a total return of +25. 6%, compared to -79. 2% for Nu Skin Enterprises, Inc. (NUS). Over 10 years, the gap is even starker: NATR returned +195. 6% versus NUS's -49. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Nature's Sunshine Products, Inc.

(NATR) is the lower-risk stock at 0. 62β versus Nu Skin Enterprises, Inc. 's 1. 49β — meaning NUS is approximately 139% more volatile than NATR relative to the S&P 500. On balance sheet safety, Nature's Sunshine Products, Inc. (NATR) carries a lower debt/equity ratio of 12% versus 35% for Nu Skin Enterprises, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Nature's Sunshine Products, Inc.

(NATR) is pulling ahead at 5. 7% versus -14. 3% for Nu Skin Enterprises, Inc. (NUS). On earnings-per-share growth, the picture is similar: Nu Skin Enterprises, Inc. grew EPS 207. 8% year-over-year, compared to 165. 0% for Nature's Sunshine Products, Inc.. Over a 3-year CAGR, NATR leads at 4. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Nu Skin Enterprises, Inc.

(NUS) is the more profitable company, earning 10. 8% net margin versus 4. 1% for Nature's Sunshine Products, Inc. — meaning it keeps 10. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NATR leads at 5. 2% versus 4. 4% for NUS. At the gross margin level — before operating expenses — NATR leads at 69. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Nu Skin Enterprises, Inc.

(NUS) trades at 7. 3x forward P/E versus 23. 4x for Nature's Sunshine Products, Inc. — 16. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NUS: 49. 9% to $11. 00.

In this comparison, NUS (3.

2% yield) pays a dividend. NATR does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Nature's Sunshine Products, Inc.

(NATR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 62), +195. 6% 10Y return). Both have compounded well over 10 years (NATR: +195. 6%, NUS: -49. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Consumer Defensive sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: NATR is a small-cap quality compounder stock; NUS is a small-cap deep-value stock. NUS pays a dividend while NATR does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.